en

PRODUCT DETAIL

Talzenna 0,25 mg tvrdé kapsuly

Code 2069D
MA number EU/1/19/1377/003
Product Form: cps dur 60x1x0,25 mg (blis.PVC/PVDC-jedn.d.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors
L01XK04 Talazoparib
Shelf life: 48
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 20.06.2019
Validity: 20.06.2024
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 07.04.2022
eu-flag.png sk-flag.png